Catalyst Wire Dossier Catalyst Wire Dossier

TRUVADA

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE · Gilead Sciences, Inc
Drug timelines are a Plus or Pro feature.

106 regulatory and trial events tracked for TRUVADA, covering 2007-05-21 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) [Phase 3]

See pricing